阿里拉姆制藥 ALNY 深 滬
等待開盤 10-10 09:30:00 美东时间
454.98
+4.300
+0.95%
華盛通- 最 高459.57
- 今 開451.00
- 成交量 73.26万股
- 最 低 449.88
- 昨 收 450.68
- 總市值 596.02亿
- 52周最高 484.21
- 市盈率 靜 --
- 換手率 0.56%
- 52周最低 205.87
- 委 比 96.61%
- 總股本 1.31亿
- 歷史最高 484.21
- 量 比 0.77
- 振 幅 2.15%
- 歷史最低 5.879
- 每 手 1
- 風險率 74.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
Alnylam Begins Global Phase 3 Trial Testing New Hypertension Drug Zilebesiran, Doses First Patient In Study Of RNAi Therapy For High Blood Pressure
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in Hypertension), a global
10-01 19:36
Goldman's 48 potential M&A candidates
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
09-29 03:14
TMT Notes | AI半导体/英伟达/Marvell/美光/存储/设备
（来源：纳指弹幕组） *原则: 定期更新, 专注美股TMT及配套供应链；仅转述归纳外资研报观点，不展示研报原文，保护研报版权；无精力做知识星球, 不...
09-28 20:45
申万宏源：预计全球小核酸药物市场将加速增长 关注后续临床数据读出以及潜在海外授权
在技术持续进步、上市批准及临床验证不断增加的推动下，预计全球小核酸药物市场将加速增长，从2023年起以26.1%的复合年增长率在2033年达到467亿美元。 ...
09-26 10:19
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
Monopar Therapeutics Inc. announced that the *Journal of Hepatology* published a peer-reviewed Letter to the Editor authored by leading Wilson disease physicians, highlighting that ALXN1840 statistically significantly improved copper balance in patients with Wilson disease. The study addressed a methodological limitation in earlier analysis by accounting for additional copper loss routes, demonstrating ALXN1840’s efficacy. Cumulative mean copper ...
09-24 03:07
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Jefferies sees broad equity opportunities beyond tech leaders
With the S&P 500 (SP500) up 13% year-to-date but gains concentrated in a narrow group of large-cap technology names, Jefferies analysts argue that investors still have ample opportunity to find winner...
09-21 22:13
探索价值投资在创新药领域的深度适配与融合 | 巴伦精选
2025年7月份，东方马拉松团队非常荣幸在百年财经Barron's巴伦中文网发表过《探究争论不休的世纪话题：科技公司与价值投资如何适配融合？》一文，探讨了价值投...
09-21 09:32
